Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
New York, NY, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the official launch of the Company’s new 100,000 square foot state-of-the-art laboratory and research facilities in Farmingdale, New York. The launch event being held this morning at 11:00 AM ET at the new Enzo headquarters will feature an outline of the Company’s plans for growth in many new areas of diagnostics, life sciences, and clinical laboratory service, and will include comments regarding the business community on Long Island from New York dignitaries.
- Enzo Biochem is a global healthcare company that offers a range of products and services to support medical research and life sciences drug development as well as clinical diagnostic services.
- With the opening of the companys new facilities in Farmingdale, Enzo has expanded its manufacturing operations while increasing job opportunities at its Long Island based facility.
- It is also a confirmation of our continued commitment to the business community here on Long Island, said Hamid Erfanian, CEO of Enzo Biochem.
- The program also includes a tour of the new laboratory facilities highlighting some of the most advanced technologies available today in clinical laboratory operations and diagnostic services.